A股異動丨“妖股”宇晶股份復牌大跌超8% 此前11個交易日暴漲超130%
格隆匯12月2日丨宇晶股份今日復牌,開盤直接低開低走,現大跌超8%,報41.5元,總市值41.5億元。11月10日-11月24日,11個交易日時間,宇晶股份走出8個漲停,股價累計漲幅達131.9%。11月24日晚間,宇晶股份發佈公吿稱,因近期公司股價異常波動,申請自11月25日開市起停牌。宇晶股份此前股價暴漲,主要是由於工業母機概念炒作。據央視財經,在疫情衝擊全球產業鏈供應鏈的背景下,中國製造業率先實現復工復產。受益於製造業需求拉動,工業母機企業也出現訂單爆滿、一機難求的景象。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.